Old Web
English
Sign In
Acemap
>
authorDetail
>
Barbara Wenrich
Barbara Wenrich
AstraZeneca
Internal medicine
Oral administration
Pharmacology
Pharmacodynamics
Cediranib
3
Papers
115
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase 1 Trial and Pharmacokinetic Study of Cediranib, an Orally Bioavailable Pan–Vascular Endothelial Growth Factor Receptor Inhibitor, in Children and Adolescents With Refractory Solid Tumors
2010
Journal of Clinical Oncology
Elizabeth Fox
Richard Aplenc
Rochelle Bagatell
Meredith K. Chuk
Eva Dombi
Wendy Goodspeed
Anne Goodwin
Marie Kromplewski
Nalini Jayaprakash
Marcelo Marotti
Kathryn H. Brown
Barbara Wenrich
Peter C. Adamson
Brigitte C. Widemann
Frank M. Balis
Show All
Source
Cite
Save
Citations (88)
Abstract A5: Phase I trial and pharmacokinetic study of cediranib in children with recurrent or refractory solid tumors
2009
Molecular Cancer Therapeutics
Elizabeth Fox
Richard Aplenc
Brigitte C. Widemann
Meredith K. Chuk
Rochelle Bagatell
Anne Goodwin
Wendy Goodspeed
Marie Kromplewski
Barbara Wenrich
Kathryn H. Brown
Marcelo Marotti
Peter C. Adamson
Frank M. Balis
Show All
Source
Cite
Save
Citations (0)
Pharmacological Characterization of ZD6021: A Novel, Orally Active Antagonist of the Tachykinin Receptors
2001
Journal of Pharmacology and Experimental Therapeutics
William L. Rumsey
David Aharony
Russell Bialecki
Brian M. Abbott
Herbert Barthlow
Robert Caccese
Smita V. Ghanekar
David Lengel
Michelle Mccarthy
Barbara Wenrich
Bradley J. Undem
Cyrus John Ohnmacht
Ashok Shenvi
Jeffrey S. Albert
Fred J. Brown
Peter Bernstein
Keith Russell
Show All
Source
Cite
Save
Citations (27)
1